SA PRO
Free Account
Fulgent Genetics, Inc.FLGTNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 67% recommend buying.

Consensus Rating
Buy
9 analysts·Limited coverage
67%
Rating Distribution
Strong Buy
00%
Buy
667%
Hold
333%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 52% higher.

Bear Case
$36.00
+52%
Consensus
$36.00
+52%
Bull Case
$36.00
+52%
Price Range9 analysts
Low
Consensus
High
$36.00
$36.00
Current Target
Current Price
$23.71
Upside to Target
$12.29

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.32(2 analysts)
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+9.87%
EPS—
FY2028
Rev+9.87%
EPS—

Earnings Surprises

Beat rate:92%(11/12 quarters)
Avg surprise:+112.3%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Nov 14, 2025Raymond James
Fulgent Genetics (FLGT) PT Raised to $36 at Raymond James
Target:$36.00
+21.7%from $29.59
Aug 5, 2025UBS
Fulgent Genetics upgraded to Buy from Neutral at UBS
Target:$30.00
+44.4%from $20.78
Aug 4, 2025Piper Sandler
Fulgent Genetics price target lowered to $21 from $23 at Piper Sandler
Target:$21.00
+14.4%from $18.36
May 5, 2025Raymond James
Fulgent Genetics price target raised to $25 from $24 at Raymond James
Target:$25.00
+27.8%from $19.56
Dec 8, 2022Piper Sandler
Piper Sandler Downgrades Fulgent Genetics to Neutral, Lowers Price Target to $40
Target:$40.00
+7.9%from $37.07
Nov 18, 2022Raymond James
Raymond James Initiates Coverage On Fulgent Genetics with Outperform Rating, Announces Price Target of $45
Target:$45.00
+25.4%from $35.89
Nov 14, 2022Credit Suisse
Credit Suisse Maintains Outperform on Fulgent Genetics, Lowers Price Target to $50
Target:$50.00
+27.4%from $39.24
May 15, 2022Piper Sandler
Fulgent Genetics price target lowered to $70 from $85 at Piper Sandler
Target:$70.00
+28.6%from $54.45

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance